Literature DB >> 31314977

Tofacitinib in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease.

Zhiwei Chen1, Xiaodong Wang1, Shuang Ye1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31314977     DOI: 10.1056/NEJMc1900045

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  41 in total

Review 1.  Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis.

Authors:  Wanlong Wu; Li Guo; Yakai Fu; Kaiwen Wang; Danting Zhang; Wenwen Xu; Zhiwei Chen; Shuang Ye
Journal:  Clin Rev Allergy Immunol       Date:  2021-01-06       Impact factor: 8.667

Review 2.  Idiopathic inflammatory myopathies.

Authors:  Ingrid E Lundberg; Manabu Fujimoto; Jiri Vencovsky; Rohit Aggarwal; Marie Holmqvist; Lisa Christopher-Stine; Andrew L Mammen; Frederick W Miller
Journal:  Nat Rev Dis Primers       Date:  2021-12-02       Impact factor: 52.329

3.  Skin Rash and Interstitial Pneumonia Can Be a Fatal Combination: A Rare Case of Anti-Melanoma Differentiation-Associated Gene 5 (MDA5)-Associated Interstitial Lung Disease.

Authors:  Giorgia Borio; Chiara Terracciano; Federico Buttafava; Andrea Vercelli; Laura Pagani; Chiara Zanzani; Alessandra Manicardi; Andrea Magnacavallo; Erika Poggiali
Journal:  Eur J Case Rep Intern Med       Date:  2021-10-18

Review 4.  Interfering with interferons: targeting the JAK-STAT pathway in complications of systemic juvenile idiopathic arthritis (SJIA).

Authors:  Emely L Verweyen; Grant S Schulert
Journal:  Rheumatology (Oxford)       Date:  2022-03-02       Impact factor: 7.046

Review 5.  [Pharmacology of Janus kinase inhibitors].

Authors:  F Solimani; F J Hilke; K Ghoreschi
Journal:  Hautarzt       Date:  2019-12       Impact factor: 0.751

Review 6.  Myositis-associated interstitial lung disease: a comprehensive approach to diagnosis and management.

Authors:  Robert W Hallowell; Julie J Paik
Journal:  Clin Exp Rheumatol       Date:  2021-03-25       Impact factor: 4.473

7.  Rheumatoid arthritis-associated interstitial lung disease: Current update on prevalence, risk factors, and pharmacologic treatment.

Authors:  Sicong Huang; Vanessa L Kronzer; Paul F Dellaripa; Kevin D Deane; Marcy B Bolster; Vivek Nagaraja; Dinesh Khanna; Tracy J Doyle; Jeffrey A Sparks
Journal:  Curr Treatm Opt Rheumatol       Date:  2020-09-01

Review 8.  Type I Interferons in Systemic Autoimmune Diseases: Distinguishing Between Afferent and Efferent Functions for Precision Medicine and Individualized Treatment.

Authors:  François Chasset; Jean-Michel Dayer; Carlo Chizzolini
Journal:  Front Pharmacol       Date:  2021-04-14       Impact factor: 5.810

Review 9.  A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future?

Authors:  Christine Liu; Jacqueline Kieltyka; Roy Fleischmann; Massimo Gadina; John J O'Shea
Journal:  Arthritis Rheumatol       Date:  2021-11-02       Impact factor: 15.483

10.  Noninvasive positive pressure ventilator deteriorates the outcome of pneumomediastinum in anti-MDA5 antibody-positive clinically amyopathic dermatomyositis.

Authors:  Mengmeng Zhou; Yan Ye; Ninghui Yan; Xinyue Lian; Chunde Bao; Qiang Guo
Journal:  Clin Rheumatol       Date:  2020-01-15       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.